{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:52:44Z","timestamp":1792155164790,"version":"4.4.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,27]]},"DOI":"10.7759\/cureus.27322","type":"journal-article","created":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T07:46:45Z","timestamp":1658908005000},"source":"Crossref","is-referenced-by-count":4,"title":["Hepatitis Virus C-associated Nephropathy: A Review and Update"],"prefix":"10.7759","author":[{"given":"Elmukhtar","family":"Habas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalifa L","family":"Farfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Errayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ala M","family":"Habas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Errayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamal","family":"Alfitori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amnna","family":"Rayani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elgara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha H","family":"Al Adab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulnaser","family":"Elzouki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158765","article-title":"Global prevalence of chronic kidney disease - a systematic review and meta-analysis","volume":"11","author":"Hill NR","year":"2016","unstructured":"Hill NR, Fatoba ST, Oke JL, Hirst JA, O'Callaghan CA, Lasserson DS, Hobbs FD. Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PLoS One. 2016, 11:e0158765. 10.1371\/journal.pone.0158765","journal-title":"PLoS One"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)62004-3","article-title":"Early recognition and prevention of chronic kidney disease","volume":"375","author":"James MT","year":"2010","unstructured":"James MT, Hemmelgarn BR, Tonelli M. Early recognition and prevention of chronic kidney disease. Lancet. 2010, 375:1296-309. 10.1016\/S0140-6736(09)62004-3","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.kisu.2021.11.003","article-title":"Epidemiology of chronic kidney disease: an update 2022","volume":"12","author":"Kovesdy CP","year":"2022","unstructured":"Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl (2011). 2022, 12:7-11. 10.1016\/j.kisu.2021.11.003","journal-title":"Kidney Int Suppl (2011)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/jorc.12316","article-title":"Kidney health for everyone everywhere-from prevention to detection and equitable access to care","volume":"46","author":"Li PK","year":"2020","unstructured":"Li PK, Garcia-Garcia G, Lui SF, et al.. Kidney health for everyone everywhere-from prevention to detection and equitable access to care. J Ren Care. 2020, 46:4-12. 10.1111\/jorc.12316","journal-title":"J Ren Care"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv466","article-title":"Chronic kidney disease in low- and middle-income countries","volume":"31","author":"Stanifer JW","year":"2016","unstructured":"Stanifer JW, Muiru A, Jafar TH, Patel UD. Chronic kidney disease in low- and middle-income countries. Nephrol Dial Transplant. 2016, 31:868-74. 10.1093\/ndt\/gfv466","journal-title":"Nephrol Dial Transplant"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.368","article-title":"The contribution of chronic kidney disease to the global burden of major noncommunicable diseases","volume":"80","author":"Couser WG","year":"2011","unstructured":"Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011, 80:1258-70. 10.1038\/ki.2011.368","journal-title":"Kidney Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Mohd Hanafiah K","year":"2013","unstructured":"Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013, 57:1333-42. 10.1002\/hep.26141","journal-title":"Hepatology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2016.176","article-title":"Global epidemiology and burden of HCV infection and HCV-related disease","volume":"14","author":"Thrift AP","year":"2017","unstructured":"Thrift AP, El-Serag HB, Kanwal F. Global epidemiology and burden of HCV infection and HCV-related disease. Nat Rev Gastroenterol Hepatol. 2017, 14:122-32. 10.1038\/nrgastro.2016.176","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00472-6","article-title":"Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study","volume":"7","year":"2022","unstructured":"Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020. a modelling study. Lancet Gastroenterol Hepatol. 2022, 7:396-415. 10.1016\/S2468-1253(21)00472-6","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s42399-020-00588-3","article-title":"Update on hepatitis C epidemiology: unaware and untreated infected population could be the key to elimination","volume":"2","author":"Stasi C","year":"2020","unstructured":"Stasi C, Silvestri C, Voller F. Update on hepatitis C epidemiology: unaware and untreated infected population could be the key to elimination. SN Compr Clin Med. 2020, 2:2808-15. 10.1007\/s42399-020-00588-3","journal-title":"SN Compr Clin Med"},{"key":"ref11","unstructured":"Eliminate hepatitis. WHO. (2017). Accessed: June 24, 2022: https:\/\/www.who.int\/news\/item\/27-07-2017-eliminate-hepatitis-who."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2019.24.30.1800695","article-title":"Mortality rates among individuals diagnosed with hepatitis C virus (HCV); an observational cohort study, England, 2008 to 2016","volume":"24","author":"Ireland G","year":"2019","unstructured":"Ireland G, Mandal S, Hickman M, Ramsay M, Harris R, Simmons R. Mortality rates among individuals diagnosed with hepatitis C virus (HCV); an observational cohort study, England, 2008 to 2016. Euro Surveill. 2019, 24:1800695. 10.2807\/1560-7917.ES.2019.24.30.1800695","journal-title":"Euro Surveill"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.36791","article-title":"The burden of hepatitis C in the United States","volume":"36","author":"Kim WR","year":"2002","unstructured":"Kim WR. The burden of hepatitis C in the United States. Hepatology. 2002, 36:S30-4. 10.1053\/jhep.2002.36791","journal-title":"Hepatology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(99)06527-7","article-title":"The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt","volume":"355","author":"Frank C","year":"2000","unstructured":"Frank C, Mohamed MK, Strickland GT, et al.. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet. 2000, 355:887-91. 10.1016\/s0140-6736(99)06527-7","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/265353","article-title":"Autophagy in HCV infection: keeping fat and inflammation at bay","volume":"2014","author":"Vescovo T","year":"2014","unstructured":"Vescovo T, Refolo G, Romagnoli A, Ciccosanti F, Corazzari M, Alonzi T, Fimia GM. Autophagy in HCV infection: keeping fat and inflammation at bay. Biomed Res Int. 2014, 2014:265353. 10.1155\/2014\/265353","journal-title":"Biomed Res Int"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-009-9158-6","article-title":"Role of free radicals in liver diseases","volume":"3","author":"Muriel P","year":"2009","unstructured":"Muriel P. Role of free radicals in liver diseases. Hepatol Int. 2009, 3:526-36. 10.1007\/s12072-009-9158-6","journal-title":"Hepatol Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(00)80080-x","article-title":"Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histological severity of liver disease","volume":"32","author":"Garc\u00eda-Monz\u00f3n C","year":"2000","unstructured":"Garc\u00eda-Monz\u00f3n C, Majano PL, Zubia I, Sanz P, Apolinario A, Moreno-Otero R. Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histological severity of liver disease. J Hepatol. 2000, 32:331-8. 10.1016\/s0168-8278(00)80080-x","journal-title":"J Hepatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajg.2022.01.005","article-title":"Update on hepatorenal syndrome: definition, pathogenesis, and management","volume":"23","author":"Habas E","year":"2022","unstructured":"Habas E, Ibrahim AR, Moursi MO, Shraim BA, Elgamal ME, Elzouki AN. Update on hepatorenal syndrome: definition, pathogenesis, and management. Arab J Gastroenterol. 2022, 23:125-33. 10.1016\/j.ajg.2022.01.005","journal-title":"Arab J Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00649.x","article-title":"Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS","volume":"65","author":"Fissell RB","year":"2004","unstructured":"Fissell RB, Bragg-Gresham JL, Woods JD, et al.. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int. 2004, 65:2335-42. 10.1111\/j.1523-1755.2004.00649.x","journal-title":"Kidney Int"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12413","article-title":"A meta-analytic assessment of the risk of chronic kidney disease in patients with chronic hepatitis C virus infection","volume":"22","author":"Park H","year":"2015","unstructured":"Park H, Adeyemi A, Henry L, Stepanova M, Younossi Z. A meta-analytic assessment of the risk of chronic kidney disease in patients with chronic hepatitis C virus infection. J Viral Hepat. 2015, 22:897-905. 10.1111\/jvh.12413","journal-title":"J Viral Hepat"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/hdi.12656","article-title":"Rationale for treatment of hepatitis C virus infection in end-stage renal disease patients who are not kidney transplant candidates","volume":"22 Suppl 1","author":"Al-Rabadi L","year":"2018","unstructured":"Al-Rabadi L, Box T, Singhania G, et al.. Rationale for treatment of hepatitis C virus infection in end-stage renal disease patients who are not kidney transplant candidates. Hemodial Int. 2018, 22 Suppl 1:S45-52. 10.1111\/hdi.12656","journal-title":"Hemodial Int"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2018.202","article-title":"Hepatitis C virus infection in chronic kidney disease: paradigm shift in management","volume":"33","author":"Kim SM","year":"2018","unstructured":"Kim SM, Song IH. Hepatitis C virus infection in chronic kidney disease: paradigm shift in management. Korean J Intern Med. 2018, 33:670-8. 10.3904\/kjim.2018.202","journal-title":"Korean J Intern Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000131948.29742.24","article-title":"Hepatitis C infection, time in renal-replacement therapy, and outcome after kidney transplantation","volume":"78","author":"Bruchfeld A","year":"2004","unstructured":"Bruchfeld A, Wilczek H, Elinder CG. Hepatitis C infection, time in renal-replacement therapy, and outcome after kidney transplantation. Transplantation. 2004, 78:745-50. 10.1097\/01.tp.0000131948.29742.24","journal-title":"Transplantation"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/cld.791","article-title":"AASLD\/IDSA HCV guidance: recommendations for testing, managing, and treating hepatitis C","volume":"12","year":"2018","unstructured":"AASLD\/IDSA HCV guidance. recommendations for testing, managing, and treating hepatitis C. Clin Liver Dis (Hoboken). 2018, 12:117. 10.1002\/cld.791","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-308163","article-title":"Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection","volume":"64","author":"Hsu YC","year":"2015","unstructured":"Hsu YC, Ho HJ, Huang YT, Wang HH, Wu MS, Lin JT, Wu CY. Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection. Gut. 2015, 64:495-503. 10.1136\/gutjnl-2014-308163","journal-title":"Gut"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis385","article-title":"Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study","volume":"206","author":"Lee MH","year":"2012","unstructured":"Lee MH, Yang HI, Lu SN, et al.. Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study. J Infect Dis. 2012, 206:469-77. 10.1093\/infdis\/jis385","journal-title":"J Infect Dis"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2018.06.011","article-title":"Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management","volume":"94","author":"Jadoul M","year":"2018","unstructured":"Jadoul M, Berenguer MC, Doss W, et al.. Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management. Kidney Int. 2018, 94:663-73. 10.1016\/j.kint.2018.06.011","journal-title":"Kidney Int"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2018.11.038","article-title":"Prevalence, incidence, and risk factors for hepatitis C virus infection in hemodialysis patients","volume":"95","author":"Jadoul M","year":"2019","unstructured":"Jadoul M, Bieber BA, Martin P, et al.. Prevalence, incidence, and risk factors for hepatitis C virus infection in hemodialysis patients. Kidney Int. 2019, 95:939-47. 10.1016\/j.kint.2018.11.038","journal-title":"Kidney Int"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-018-0081-8","article-title":"Hepatitis C virus and the kidney","volume":"15","author":"Pol S","year":"2019","unstructured":"Pol S, Parlati L, Jadoul M. Hepatitis C virus and the kidney. Nat Rev Nephrol. 2019, 15:73-86. 10.1038\/s41581-018-0081-8","journal-title":"Nat Rev Nephrol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.179","article-title":"HCV transmission in industrialized countries and resource-constrained areas","volume":"11","author":"Thursz M","year":"2014","unstructured":"Thursz M, Fontanet A. HCV transmission in industrialized countries and resource-constrained areas. Nat Rev Gastroenterol Hepatol. 2014, 11:28-35. 10.1038\/nrgastro.2013.179","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13367","article-title":"Epidemiology update for hepatitis C virus and hepatitis B virus in end-stage renal disease in France","volume":"37","author":"Isnard Bagnis C","year":"2017","unstructured":"Isnard Bagnis C, Couchoud C, Bowens M, et al.. Epidemiology update for hepatitis C virus and hepatitis B virus in end-stage renal disease in France. Liver Int. 2017, 37:820-6. 10.1111\/liv.13367","journal-title":"Liver Int"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2018.02.009","article-title":"International prevalence of hepatitis C positivity among hemodialysis patients awaiting transplantation","volume":"93","author":"Goodkin DA","year":"2018","unstructured":"Goodkin DA, Bieber B. International prevalence of hepatitis C positivity among hemodialysis patients awaiting transplantation. Kidney Int. 2018, 93:1249. 10.1016\/j.kint.2018.02.009","journal-title":"Kidney Int"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.07940716","article-title":"Mortality, hospitalization, and quality of life among patients with hepatitis C infection on hemodialysis","volume":"12","author":"Goodkin DA","year":"2017","unstructured":"Goodkin DA, Bieber B, Jadoul M, Martin P, Kanda E, Pisoni RL. Mortality, hospitalization, and quality of life among patients with hepatitis C infection on hemodialysis. Clin J Am Soc Nephrol. 2017, 12:287-97. 10.2215\/CJN.07940716","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-011-9284-9","article-title":"Higher prevalence of chronic kidney disease and shorter renal survival in patients with chronic hepatitis C virus infection","volume":"6","author":"Satapathy SK","year":"2012","unstructured":"Satapathy SK, Lingisetty CS, Williams S. Higher prevalence of chronic kidney disease and shorter renal survival in patients with chronic hepatitis C virus infection. Hepatol Int. 2012, 6:369-78. 10.1007\/s12072-011-9284-9","journal-title":"Hepatol Int"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29505","article-title":"Chronic hepatitis C virus (HCV) increases the risk of chronic kidney disease (CKD) while effective HCV treatment decreases the incidence of CKD","volume":"67","author":"Park H","year":"2018","unstructured":"Park H, Chen C, Wang W, Henry L, Cook RL, Nelson DR. Chronic hepatitis C virus (HCV) increases the risk of chronic kidney disease (CKD) while effective HCV treatment decreases the incidence of CKD. Hepatology. 2018, 67:492-504. 10.1002\/hep.29505","journal-title":"Hepatology"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2012.04.003","article-title":"Association of hepatitis C virus infection with risk of ESRD: a population-based study","volume":"60","author":"Su FH","year":"2012","unstructured":"Su FH, Su CT, Chang SN, Chen PC, Sung FC, Lin CC, Yeh CC. Association of hepatitis C virus infection with risk of ESRD: a population-based study. Am J Kidney Dis. 2012, 60:553-60. 10.1053\/j.ajkd.2012.04.003","journal-title":"Am J Kidney Dis"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1994.393","article-title":"Renal manifestations of hepatitis C virus infection","volume":"46","author":"Johnson RJ","year":"1994","unstructured":"Johnson RJ, Willson R, Yamabe H, et al.. Renal manifestations of hepatitis C virus infection. Kidney Int. 1994, 46:1255-63. 10.1038\/ki.1994.393","journal-title":"Kidney Int"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i24.7544","article-title":"Hepatitis C virus associated glomerulopathies","volume":"20","author":"Ozkok A","year":"2014","unstructured":"Ozkok A, Yildiz A. Hepatitis C virus associated glomerulopathies. World J Gastroenterol. 2014, 20:7544-54. 10.3748\/wjg.v20.i24.7544","journal-title":"World J Gastroenterol"},{"key":"ref39","article-title":"Hepatitis C virus-related kidney disease: various histological patterns","volume":"74","author":"Sumida K","year":"2010","unstructured":"Sumida K, Ubara Y, Hoshino J, et al.. Hepatitis C virus-related kidney disease: various histological patterns. Clin Nephrol. 2010, 74:446-56.","journal-title":"Clin Nephrol"},{"key":"ref40","article-title":"Cryoglobulinemia","author":"Bhandari J","year":"2022","unstructured":"Bhandari J, Awais M, Aeddula NR. Cryoglobulinemia. StatPearls Publishing, Treasure Island, FL; 2022."},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201809_15943","article-title":"IgG cryoglobulinemia","volume":"22","author":"Gulli F","year":"2018","unstructured":"Gulli F, Basile U, Gragnani L, et al.. IgG cryoglobulinemia. Eur Rev Med Pharmacol Sci. 2018, 22:6057-62. 10.26355\/eurrev_201809_15943","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/980942","article-title":"HCV and lymphoproliferation","volume":"2012","author":"Zignego AL","year":"2012","unstructured":"Zignego AL, Giannini C, Gragnani L. HCV and lymphoproliferation. Clin Dev Immunol. 2012, 2012:980942. 10.1155\/2012\/980942","journal-title":"Clin Dev Immunol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(74)90852-3","article-title":"Biologic and clinical significance of cryoglobulins. A report of 86 cases","volume":"57","author":"Brouet JC","year":"1974","unstructured":"Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med. 1974, 57:775-88. 10.1016\/0002-9343(74)90852-3","journal-title":"Am J Med"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1136\/ard.57.1.3","article-title":"Cryoglobulins are not essential","volume":"57","author":"Trendelenburg M","year":"1998","unstructured":"Trendelenburg M, Schifferli JA. Cryoglobulins are not essential. Ann Rheum Dis. 1998, 57:3-5. 10.1136\/ard.57.1.3","journal-title":"Ann Rheum Dis"},{"key":"ref45","article-title":"Comprehensive clinical nephrology","author":"Johnson RJ","year":"2018","unstructured":"Johnson RJ, Feehally J, Floege J, Tonelli M. Comprehensive clinical nephrology. Elsevier, New York; 2018."},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1002\/art.20594","article-title":"Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection","volume":"50","author":"Vallat L","year":"2004","unstructured":"Vallat L, Benhamou Y, Gutierrez M, et al.. Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection. Arthritis Rheum. 2004, 50:3668-78. 10.1002\/art.20594","journal-title":"Arthritis Rheum"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2006.09.015","article-title":"Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis","volume":"49","author":"Roccatello D","year":"2007","unstructured":"Roccatello D, Fornasieri A, Giachino O, et al.. Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis. Am J Kidney Dis. 2007, 49:69-82. 10.1053\/j.ajkd.2006.09.015","journal-title":"Am J Kidney Dis"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.nephro.2016.01.010","article-title":"[Renal involvement during type\u00a01 cryoglobulinemia]","volume":"12 Suppl 1","author":"Zaidan M","year":"2016","unstructured":"Zaidan M, Plasse F, Rabant M, et al.. [Renal involvement during type\u00a01 cryoglobulinemia]. Nephrol Ther. 2016, 12 Suppl 1:S71-81. 10.1016\/j.nephro.2016.01.010","journal-title":"Nephrol Ther"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1108178","article-title":"Membranoproliferative glomerulonephritis--a new look at an old entity","volume":"366","author":"Sethi S","year":"2012","unstructured":"Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis--a new look at an old entity. N Engl J Med. 2012, 366:1119-31. 10.1056\/NEJMra1108178","journal-title":"N Engl J Med"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2005.01.013","article-title":"HCV associated glomerulopathy in Egyptian patients: clinicopathological analysis","volume":"334","author":"Sabry A","year":"2005","unstructured":"Sabry A, E-Agroudy A, Sheashaa H, El-Husseini A, Mohamed Taha N, Elbaz M, Sobh M. HCV associated glomerulopathy in Egyptian patients: clinicopathological analysis. Virology. 2005, 334:10-6. 10.1016\/j.virol.2005.01.013","journal-title":"Virology"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510250529","article-title":"Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis","volume":"25","author":"Sansonno D","year":"1997","unstructured":"Sansonno D, Gesualdo L, Manno C, Schena FP, Dammacco F. Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis. Hepatology. 1997, 25:1237-44. 10.1002\/hep.510250529","journal-title":"Hepatology"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/0019-2791(75)90046-4","article-title":"Studies on the cryoprecipitation of a human IGG3 cryoglobulin: the effects of temperature-induced comformational changes on the primary interaction","volume":"12","author":"Saulk PH","year":"1975","unstructured":"Saulk PH, Clem W. Studies on the cryoprecipitation of a human IGG3 cryoglobulin: the effects of temperature-induced comformational changes on the primary interaction. Immunochemistry. 1975, 12:29-37. 10.1016\/0019-2791(75)90046-4","journal-title":"Immunochemistry"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.8.4644","article-title":"A transgenic mouse model of autoimmune glomerulonephritis and necrotizing arteritis associated with cryoglobulinemia","volume":"169","author":"Kikuchi S","year":"2002","unstructured":"Kikuchi S, Pastore Y, Fossati-Jimack L, et al.. A transgenic mouse model of autoimmune glomerulonephritis and necrotizing arteritis associated with cryoglobulinemia. J Immunol. 2002, 169:4644-50. 10.4049\/jimmunol.169.8.4644","journal-title":"J Immunol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780361003","article-title":"Hepatitis C virus infection in type II mixed cryoglobulinemia","volume":"36","author":"Abel G","year":"1993","unstructured":"Abel G, Zhang QX, Agnello V. Hepatitis C virus infection in type II mixed cryoglobulinemia. Arthritis Rheum. 1993, 36:1341-9. 10.1002\/art.1780361003","journal-title":"Arthritis Rheum"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2019.00020","article-title":"HCV-associated nephropathies in the era of direct acting antiviral agents","volume":"6","author":"Angeletti A","year":"2019","unstructured":"Angeletti A, Cantarelli C, Cravedi P. HCV-associated nephropathies in the era of direct acting antiviral agents. Front Med (Lausanne). 2019, 6:20. 10.3389\/fmed.2019.00020","journal-title":"Front Med (Lausanne)"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei278","article-title":"Type II mixed cryoglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses","volume":"45","author":"De Re V","year":"2006","unstructured":"De Re V, De Vita S, Sansonno D, et al.. Type II mixed cryoglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses. Rheumatology (Oxford). 2006, 45:685-93. 10.1093\/rheumatology\/kei278","journal-title":"Rheumatology (Oxford)"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab157","article-title":"Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression","volume":"60","author":"Pocino K","year":"2021","unstructured":"Pocino K, Napodano C, Gragnani L, et al.. Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression. Rheumatology (Oxford). 2021, 60:4418-27. 10.1093\/rheumatology\/keab157","journal-title":"Rheumatology (Oxford)"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199302183280711","article-title":"Immune-complex glomerulonephritis--deposits plus interest","volume":"328","author":"Appel GB","year":"1993","unstructured":"Appel GB. Immune-complex glomerulonephritis--deposits plus interest. N Engl J Med. 1993, 328:505-6. 10.1056\/NEJM199302183280711","journal-title":"N Engl J Med"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V62220","article-title":"Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan","volume":"6","author":"Yamabe H","year":"1995","unstructured":"Yamabe H, Johnson RJ, Gretch DR, et al.. Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan. J Am Soc Nephrol. 1995, 6:220-3. 10.1681\/ASN.V62220","journal-title":"J Am Soc Nephrol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-018-0514-5","article-title":"HCV-negative mixed cryoglobulinemia and kidney involvement: in-depth review on physiopathological and histological bases","volume":"18","author":"Spatola L","year":"2018","unstructured":"Spatola L, Generali E, Angelini C, Badalamenti S, Selmi C. HCV-negative mixed cryoglobulinemia and kidney involvement: in-depth review on physiopathological and histological bases. Clin Exp Med. 2018, 18:465-71. 10.1007\/s10238-018-0514-5","journal-title":"Clin Exp Med"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2015.06.003","article-title":"Glomerular diseases associated with hepatitis B and C","volume":"22","author":"Gupta A","year":"2015","unstructured":"Gupta A, Quigg RJ. Glomerular diseases associated with hepatitis B and C. Adv Chronic Kidney Dis. 2015, 22:343-51. 10.1053\/j.ackd.2015.06.003","journal-title":"Adv Chronic Kidney Dis"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.5414\/cnp60364","article-title":"Crescentic fibrillary glomerulonephritis associated with hepatitis C viral infection","volume":"60","author":"Guerra G","year":"2003","unstructured":"Guerra G, Narayan G, Rennke HG, Jaber BL. Crescentic fibrillary glomerulonephritis associated with hepatitis C viral infection. Clin Nephrol. 2003, 60:364-8. 10.5414\/cnp60364","journal-title":"Clin Nephrol"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1992.433","article-title":"Clinical and pathologic features of fibrillary glomerulonephritis","volume":"42","author":"Iskandar SS","year":"1992","unstructured":"Iskandar SS, Falk RJ, Jennette JC. Clinical and pathologic features of fibrillary glomerulonephritis. Kidney Int. 1992, 42:1401-7. 10.1038\/ki.1992.433","journal-title":"Kidney Int"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.1007-3418.2010.09.021","article-title":"[IgA nephropathy associated with hepatitis C virus infection: a case report]","volume":"18","author":"Ji FP","year":"2010","unstructured":"Ji FP, Li ZX, Tian CY, Ge H, Cai ZF, Pan GY. [IgA nephropathy associated with hepatitis C virus infection: a case report]. Zhonghua Gan Zang Bing Za Zhi. 2010, 18:718-9. 10.3760\/cma.j.issn.1007-3418.2010.09.021","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.4103\/0971-4065.109443","article-title":"Hepatitis C as a potential cause of IgA nephropathy","volume":"23","author":"Dey AK","year":"2013","unstructured":"Dey AK, Bhattacharya A, Majumdar A. Hepatitis C as a potential cause of IgA nephropathy. Indian J Nephrol. 2013, 23:143-5. 10.4103\/0971-4065.109443","journal-title":"Indian J Nephrol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1111\/hdi.12649","article-title":"Treatment of hepatitis C virus infection in patients with mixed cryoglobulinemic syndrome and cryoglobulinemic glomerulonephritis","volume":"22 Suppl 1","author":"Rutledge SM","year":"2018","unstructured":"Rutledge SM, Chung RT, Sise ME. Treatment of hepatitis C virus infection in patients with mixed cryoglobulinemic syndrome and cryoglobulinemic glomerulonephritis. Hemodial Int. 2018, 22 Suppl 1:S81-96. 10.1111\/hdi.12649","journal-title":"Hemodial Int"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v10.i1.1","article-title":"Role of inflammatory response in liver diseases: therapeutic strategies","volume":"10","author":"Del Campo JA","year":"2018","unstructured":"Del Campo JA, Gallego P, Grande L. Role of inflammatory response in liver diseases: therapeutic strategies. World J Hepatol. 2018, 10:1-7. 10.4254\/wjh.v10.i1.1","journal-title":"World J Hepatol"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.08.035","article-title":"Extrahepatic morbidity and mortality of chronic hepatitis C","volume":"149","author":"Negro F","year":"2015","unstructured":"Negro F, Forton D, Crax\u00ec A, Sulkowski MS, Feld JJ, Manns MP. Extrahepatic morbidity and mortality of chronic hepatitis C. Gastroenterology. 2015, 149:1345-60. 10.1053\/j.gastro.2015.08.035","journal-title":"Gastroenterology"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2012.08.040","article-title":"Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease","volume":"61","author":"Fabrizi F","year":"2013","unstructured":"Fabrizi F, Plaisier E, Saadoun D, Martin P, Messa P, Cacoub P. Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease. Am J Kidney Dis. 2013, 61:623-37. 10.1053\/j.ajkd.2012.08.040","journal-title":"Am J Kidney Dis"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01534-06","article-title":"The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells","volume":"81","author":"Koutsoudakis G","year":"2007","unstructured":"Koutsoudakis G, Herrmann E, Kallis S, Bartenschlager R, Pietschmann T. The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells. J Virol. 2007, 81:588-98. 10.1128\/JVI.01534-06","journal-title":"J Virol"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0509402102","article-title":"Activation of na\u00efve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders","volume":"102","author":"Rosa D","year":"2005","unstructured":"Rosa D, Saletti G, De Gregorio E, et al.. Activation of na\u00efve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc Natl Acad Sci U S A. 2005, 102:18544-9. 10.1073\/pnas.0509402102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref72","article-title":"Endothelial apoptosis initiates acute blood-brain barrier disruption after ionizing radiation","volume":"63","author":"Li YQ","year":"2003","unstructured":"Li YQ, Chen P, Haimovitz-Friedman A, Reilly RM, Wong CS. Endothelial apoptosis initiates acute blood-brain barrier disruption after ionizing radiation. Cancer Res. 2003, 63:5950-6.","journal-title":"Cancer Res"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002431","article-title":"Impact of HCV infection on diabetes patients for the risk of end-stage renal failure","volume":"95","author":"Hwang JC","year":"2016","unstructured":"Hwang JC, Jiang MY, Lu YH, Weng SF. Impact of HCV infection on diabetes patients for the risk of end-stage renal failure. Medicine (Baltimore). 2016, 95:e2431. 10.1097\/MD.0000000000002431","journal-title":"Medicine (Baltimore)"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-306102","article-title":"Cardiovascular diseases and HCV infection: a simple association or more?","volume":"63","author":"Petta S","year":"2014","unstructured":"Petta S, Macaluso FS, Crax\u00ec A. Cardiovascular diseases and HCV infection: a simple association or more?. Gut. 2014, 63:369-75. 10.1136\/gutjnl-2013-306102","journal-title":"Gut"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2012.01.051","article-title":"Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis","volume":"221","author":"Adinolfi LE","year":"2012","unstructured":"Adinolfi LE, Restivo L, Zampino R, et al.. Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis. Atherosclerosis. 2012, 221:496-502. 10.1016\/j.atherosclerosis.2012.01.051","journal-title":"Atherosclerosis"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.202317","article-title":"Hepatitis C infection and clearance: impact on atherosclerosis and cardiometabolic risk factors","volume":"59","author":"Mostafa A","year":"2010","unstructured":"Mostafa A, Mohamed MK, Saeed M, et al.. Hepatitis C infection and clearance: impact on atherosclerosis and cardiometabolic risk factors. Gut. 2010, 59:1135-40. 10.1136\/gut.2009.202317","journal-title":"Gut"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2014.140","article-title":"Renal histopathological findings in relation to ambulatory blood pressure in chronic kidney disease patients","volume":"38","author":"Haruhara K","year":"2015","unstructured":"Haruhara K, Tsuboi N, Koike K, et al.. Renal histopathological findings in relation to ambulatory blood pressure in chronic kidney disease patients. Hypertens Res. 2015, 38:116-22. 10.1038\/hr.2014.140","journal-title":"Hypertens Res"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2016-0040","article-title":"Pharmacogenetic analysis of hepatitis C virus related mixed cryoglobulinemia","volume":"18","author":"Cusato J","year":"2017","unstructured":"Cusato J, Boglione L, De Nicol\u00f2 A, et al.. Pharmacogenetic analysis of hepatitis C virus related mixed cryoglobulinemia. Pharmacogenomics. 2017, 18:607-11. 10.2217\/pgs-2016-0040","journal-title":"Pharmacogenomics"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2018.6558","article-title":"Correlation of CCR5 and NLRP3 gene polymorphisms with renal damage due to hepatitis C virus-related cryoglobulinemia","volume":"16","author":"Wang M","year":"2018","unstructured":"Wang M, Liu Q, Liu C. Correlation of CCR5 and NLRP3 gene polymorphisms with renal damage due to hepatitis C virus-related cryoglobulinemia. Exp Ther Med. 2018, 16:3055-9. 10.3892\/etm.2018.6558","journal-title":"Exp Ther Med"},{"key":"ref80","article-title":"Drug-induced nephrotoxicity","volume":"78","author":"Naughton CA","year":"2008","unstructured":"Naughton CA. Drug-induced nephrotoxicity. Am Fam Physician. 2008, 78:743-50.","journal-title":"Am Fam Physician"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316234","article-title":"Impact of sustained virological response on the extrahepatic manifestations of chronic hepatitis C: a meta-analysis","volume":"67","author":"Cacoub P","year":"2018","unstructured":"Cacoub P, Desbois AC, Comarmond C, Saadoun D. Impact of sustained virological response on the extrahepatic manifestations of chronic hepatitis C: a meta-analysis. Gut. 2018, 67:2025-34. 10.1136\/gutjnl-2018-316234","journal-title":"Gut"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-149-6-200809160-00006","article-title":"Brief communication: the relationship of regression of cirrhosis to outcome in chronic hepatitis C","volume":"149","author":"Mallet V","year":"2008","unstructured":"Mallet V, Gilgenkrantz H, Serpaggi J, Verkarre V, Vallet-Pichard A, Fontaine H, Pol S. Brief communication: the relationship of regression of cirrhosis to outcome in chronic hepatitis C. Ann Intern Med. 2008, 149:399-403. 10.7326\/0003-4819-149-6-200809160-00006","journal-title":"Ann Intern Med"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.09.009","article-title":"Eradication of hepatitis C virus infection in patients with cirrhosis reduces risk of liver and non-liver complications","volume":"152","author":"Nahon P","year":"2017","unstructured":"Nahon P, Bourcier V, Layese R, et al.. Eradication of hepatitis C virus infection in patients with cirrhosis reduces risk of liver and non-liver complications. Gastroenterology. 2017, 152:142-56.e2. 10.1053\/j.gastro.2016.09.009","journal-title":"Gastroenterology"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.08.030","article-title":"HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma","volume":"68","author":"Ioannou GN","year":"2017","unstructured":"Ioannou GN, Green PK, Berry K. HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma. J Hepatol. 2017, 68:25-32. 10.1016\/j.jhep.2017.08.030","journal-title":"J Hepatol"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181f92548","article-title":"Adverse impact of hepatitis C virus infection on renal replacement therapy and renal transplant patients in Australia and New Zealand","volume":"90","author":"Scott DR","year":"2010","unstructured":"Scott DR, Wong JK, Spicer TS, Dent H, Mensah FK, McDonald S, Levy MT. Adverse impact of hepatitis C virus infection on renal replacement therapy and renal transplant patients in Australia and New Zealand. Transplantation. 2010, 90:1165-71. 10.1097\/TP.0b013e3181f92548","journal-title":"Transplantation"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.00864.x","article-title":"Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies","volume":"5","author":"Fabrizi F","year":"2005","unstructured":"Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulai G. Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies. Am J Transplant. 2005, 5:1452-61. 10.1111\/j.1600-6143.2005.00864.x","journal-title":"Am J Transplant"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-018-0476-4","article-title":"HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)","volume":"31","author":"La Manna G","year":"2018","unstructured":"La Manna G. HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs). J Nephrol. 2018, 31:185-7. 10.1007\/s40620-018-0476-4","journal-title":"J Nephrol"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1590\/2175-8239-JBN-3860","article-title":"Effect of conversion from calcineurin inhibitors to everolimus on hepatitis C viremia in adult kidney transplant recipients","volume":"40","author":"Pacheco LS","year":"2018","unstructured":"Pacheco LS, Garcia VD, Pr\u00e1 RL, et al.. Effect of conversion from calcineurin inhibitors to everolimus on hepatitis C viremia in adult kidney transplant recipients. J Bras Nefrol. 2018, 40:143-50. 10.1590\/2175-8239-JBN-3860","journal-title":"J Bras Nefrol"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60709-1","article-title":"Sirolimus to replace calcineurin inhibitors? Too early yet","volume":"373","author":"Cravedi P","year":"2009","unstructured":"Cravedi P, Ruggenenti P, Remuzzi G. Sirolimus to replace calcineurin inhibitors? Too early yet. Lancet. 2009, 373:1235-6. 10.1016\/S0140-6736(09)60709-1","journal-title":"Lancet"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2015.5","article-title":"Hepatitis C and its impact on renal transplantation","volume":"11","author":"Morales JM","year":"2015","unstructured":"Morales JM, Fabrizi F. Hepatitis C and its impact on renal transplantation. Nat Rev Nephrol. 2015, 11:172-82. 10.1038\/nrneph.2015.5","journal-title":"Nat Rev Nephrol"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199506270-00006","article-title":"De novo membranoproliferative glomerulonephritis in hepatitis C virus-infected renal allograft recipients","volume":"59","author":"Roth D","year":"1995","unstructured":"Roth D, Cirocco R, Zucker K, et al.. De novo membranoproliferative glomerulonephritis in hepatitis C virus-infected renal allograft recipients. Transplantation. 1995, 59:1676-82. 10.1097\/00007890-199506270-00006","journal-title":"Transplantation"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199803150-00024","article-title":"Pretransplant hepatitis C virus infection: a predictor of proteinuria after renal transplantation","volume":"65","author":"Hestin D","year":"1998","unstructured":"Hestin D, Guillemin F, Castin N, Le Faou A, Champigneulles J, Kessler M. Pretransplant hepatitis C virus infection: a predictor of proteinuria after renal transplantation. Transplantation. 1998, 65:741-4. 10.1097\/00007890-199803150-00024","journal-title":"Transplantation"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13080","article-title":"Effect of HCV\/HIV coinfection versus HCV monoinfection in kidney transplant recipients","volume":"15","author":"Kayler LK","year":"2015","unstructured":"Kayler LK, Xia Y, Friedmann P. Effect of HCV\/HIV coinfection versus HCV monoinfection in kidney transplant recipients. Am J Transplant. 2015, 15:849-50. 10.1111\/ajt.13080","journal-title":"Am J Transplant"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173943","article-title":"HCV coinfection contributes to HIV pathogenesis by increasing immune exhaustion in CD8 T-cells","volume":"12","author":"Rall\u00f3n N","year":"2017","unstructured":"Rall\u00f3n N, Garc\u00eda M, Garc\u00eda-Samaniego J, et al.. HCV coinfection contributes to HIV pathogenesis by increasing immune exhaustion in CD8 T-cells. PLoS One. 2017, 12:e0173943. 10.1371\/journal.pone.0173943","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/104937-hepatitis-virus-c-associated-nephropathy-a-review-and-update","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:56Z","timestamp":1707507356000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/104937-hepatitis-virus-c-associated-nephropathy-a-review-and-update"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,27]]},"references-count":94,"URL":"https:\/\/doi.org\/10.7759\/cureus.27322","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,27]]}}}